Simulations Plus/$SLP
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Simulations Plus
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
Ticker
$SLP
Sector
Primary listing
Employees
213
Headquarters
Website
Simulations Plus Metrics
BasicAdvanced
$372m
-
-$3.12
1.28
-
Price and volume
Market cap
$372m
Beta
1.28
52-week high
$21.01
52-week low
$11.09
Average daily volume
491k
Financial strength
Current ratio
5.474
Quick ratio
4.862
Long term debt to equity
0.277
Total debt to equity
0.38
Profitability
EBITDA (TTM)
13.962
Gross margin (TTM)
61.97%
Net profit margin (TTM)
-77.96%
Operating margin (TTM)
13.28%
Effective tax rate (TTM)
5.30%
Revenue per employee (TTM)
$380,000
Management effectiveness
Return on assets (TTM)
3.84%
Return on equity (TTM)
-38.84%
Valuation
Price to revenue (TTM)
4.598
Price to book
2.78
Price to tangible book (TTM)
6
Price to free cash flow (TTM)
17.833
Free cash flow yield (TTM)
5.61%
Free cash flow per share (TTM)
1.031
Growth
Revenue change (TTM)
2.51%
Earnings per share change (TTM)
-965.93%
3-year revenue growth (CAGR)
13.97%
10-year revenue growth (CAGR)
15.15%
3-year earnings per share growth (CAGR)
84.07%
10-year earnings per share growth (CAGR)
27.71%
What the Analysts think about Simulations Plus
Analyst ratings (Buy, Hold, Sell) for Simulations Plus stock.
Simulations Plus Financial Performance
Revenues and expenses
Simulations Plus Earnings Performance
Company profitability
Simulations Plus News
AllArticlesVideos
Simulations Plus (SLP) Investigation: Investors Who Suffered Losses Encouraged to Contact Johnson Fistel
Business Wire·2 weeks ago
Simulations Plus, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – SLP
Business Wire·3 weeks ago
Simulations Plus Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Simulations Plus, Inc. - SLP
Business Wire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs